My current research focuses on developing targeted, nanotechnology-based drug delivery platforms that enhance therapeutic efficacy while minimizing systemic toxicity and the emergence of drug resistance. I aspire to build a career dedicated to uncovering how biological mechanisms intersect with environmental and social determinants to drive cancer disparities. Through interdisciplinary research, scientific leadership, and evidence-based policy engagement, my long-term goal is to translate biomedical discoveries into equitable cancer solutions that measurably improve outcomes for underserved populations.